Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

145
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
145
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

197
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
197
Cancer02:18

Cancer

49.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Current opinion in pulmonary medicine·2026
Same author

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection-Reply.

Cancer discovery·2026
Same author

The Future of Lung Cancer Screening.

Archivos de bronconeumologia·2026
Same author

Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update.

Chest·2025
Same author

Baseline Characteristics of Participants and Pulmonary Nodules in the Watch the Spot Trial: A Pragmatic Trial of Less versus More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules.

Clinical lung cancer·2025
Same author

Systematic Review of the Comparative Studies of Image-Guided Thermal Ablation, Stereotactic Radiosurgery, and Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.

Seminars in thoracic and cardiovascular surgery·2024
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Aug 24, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K

Lung Cancer Screening.

Humberto K Choi1, Peter J Mazzone1

  • 1Respiratory Institute, Cleveland Clinic, 9500 Euclid Avenue Mail Code A90, Cleveland, OH 44195, USA.

The Medical Clinics of North America
|October 24, 2022
PubMed
Summary
This summary is machine-generated.

Lung cancer screening using low-dose computed tomography (LDCT) significantly reduces lung cancer deaths. High-quality screening programs require multidisciplinary teams to balance benefits with potential harms.

Keywords:
Computed tomographyLung cancerScreening

More Related Videos

Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.4K

Related Experiment Videos

Last Updated: Aug 24, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K
Lung Tumor Cell Recruitment Assay
04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.4K

Area of Science:

  • Pulmonology
  • Oncology
  • Radiology

Background:

  • Lung cancer screening with low-dose computed tomography (LDCT) offers early detection, reducing mortality.
  • The United States Preventive Services Task Force recommends LDCT for specific high-risk populations.

Purpose of the Study:

  • To outline the complex components and processes essential for implementing a high-quality lung cancer screening program.
  • To emphasize the need for balancing mortality reduction with potential screening harms.

Main Methods:

  • Identification of eligible individuals based on age and smoking history.
  • Incorporation of shared decision-making processes.
  • Standardized performance and reporting of LDCT results.
  • Management protocols for screen-detected lung nodules and non-nodule findings.
  • Integration of smoking cessation interventions.
  • Emphasis on adherence, data collection, and continuous quality improvement.

Main Results:

  • Effective lung cancer screening requires a multidisciplinary approach.
  • Careful management of findings is crucial to mitigate risks.
  • Programmatic elements must address both efficacy and safety.

Conclusions:

  • High-quality lung cancer screening programs are complex but vital for reducing lung cancer deaths.
  • Successful implementation hinges on a comprehensive strategy addressing all program components.
  • Continuous quality improvement and adherence to guidelines are paramount.